Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-dose Dual Therapy”

Showing 6 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02054286
What this trial is testing

Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

Who this might be right for
HIV Infection
Theravectys S.A. 38
Testing effectiveness (Phase 2)Ended earlyNCT00695903
What this trial is testing

Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia

Who this might be right for
Endocarditis, BacterialInfective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 38
Testing effectiveness (Phase 2)Study completedNCT01716754
What this trial is testing

Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 471
Testing effectiveness (Phase 2)Study completedNCT01319487
What this trial is testing

Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy

Who this might be right for
Diabetic Macular Edema
Fovea Pharmaceuticals SA 267
Post-approval studies (Phase 4)Study completedNCT00180167
What this trial is testing

Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC

Who this might be right for
Leukemia, Nonlymphocytic, Acute
Technische Universität Dresden 492
Large-scale testing (Phase 3)Study completedNCT00260923
What this trial is testing

A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure

Who this might be right for
Hypertension
Novartis 641

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation